CenterVue

Padova, Italy Founded: 2008 • Age: 18 yrs Acquired By Revenio Group
Fundus imaging devices are developed for ophthalmological diagnostics.

About CenterVue

CenterVue is a Technology company based in Padova (Italy) founded in 2008 by Giuliano Barbaro, and was acquired by Revenio Group in April 2019. Fundus imaging devices are developed for ophthalmological diagnostics. It operates in the Technology and Healthcare sectors. CenterVue has raised $911 thousand across 1 funding round from investors including Revenio Group and Sofimac Investment Managers. Its chief executive, as recorded, is Giuliano Barbaro. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Imaging.

Company details

CenterVue, a M31 alumnus, develops fundus imaging diagnostic devices for early detection of eye diseases such as Diabetic Retinopathy, Macular Degeneration and Glaucoma. Its products include the DRS whichis a traditional fundus camera, the Compass which is a Fundus Automated Perimeter that combines Visual Field measurement to TrueColor Confocal Imaging of the optic disc and RNFL, the Eidon is the a TrueColor Confocal Scanner that combines the advantages of SLO with the fidelity of true color fundus imaging, and the Maia device combines Images, Sensitivity and Fixation analysis for confocal microperimetry to assess macula integrity. Apart from these devices, Centervue also provides EKN which is an internet based software system, integrated with the DRS fundus camera and used to transmit retinal images and textual information, making them available for online consultation by authorized users, via the regular internet browser. CenterVue sells its products worldwide in more than 70 countries and a US subsidiary was started in 2010.

Key Metrics
  • Total Equity Funding
    $911K (USD)

    in 1 rounds

  • Latest Funding Round
    $911K (USD), Seed

    Jun 2011

  • Investors
  • Acquired by
    Revenio Group

    (Apr 2019)

Apps and channels of CenterVue

its YouTube channel iCare has 2.24K subscribers and 30 videos.

iCare
YouTube 2.24K subscribers 30 videos Science & Technology
Open channel

Videos from CenterVue

The most watched videos on CenterVue's YouTube channel, iCare (2.24K subscribers). Click a video to play it here.

iCare EIDON Family
281.7K views
iCare ILLUME - Software Solutions
32.5K views
iCare EIDON UWF Module
22K views
iCare HOME2 – Medición de la presión ocular con un tonómetro iCare HOME2 (Spanish)
8.3K views

More on iCare.

Funding Insights of CenterVue

CenterVue has successfully raised a total of $911K through 1 strategic funding round. The most recent funding activity was a Seed round of $911 thousand completed in June 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $911,000
  • Total Rounds 1
  • Last Round Seed — $911,000
  • First Round $911,000

    (Jun 2011)

  • Investors Count 1

All 1 funding rounds of CenterVue with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2011$911,000Seed––
Valuation history

2 investors in total: 2 institutional.

Investors in CenterVue

CenterVue has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Revenio Group and Sofimac Investment Managers.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
sofimac-im.com
Diagnostic devices for medical applications are developed and commercialized.
2001reveniogroup.fiVantaa, Finland
Premium access

Investor details for CenterVue

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of CenterVue

1 people are tracked at CenterVue (1 in leadership).

NameRoleGroup
Giuliano Barbaro
Co-Founder & CEOLeadership
Premium access

Complete people profiles for CenterVue

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of CenterVue

3 dated milestones of CenterVue across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded CenterVue is founded.
  2. Funding First funding round of $911K.
  3. Exit Acquired by Revenio Group.

Web traffic of CenterVue

Websites that share an audience with CenterVue (centervue.com).

Similar websites

Websites whose visitors overlap most with CenterVue. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
optomed.com
100%
9.2K#2,543,516View details
dfv.com.au
dfv.com.au
95%
#5,515,244–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Centervue

Premium access

Complete news archive for CenterVue

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CenterVue

CenterVue was founded in 2008 and raised its 1st funding round 3 years after it was founded.

CenterVue is headquartered in Padova, Italy. It is registered at Padova, Veneto, Italy.

Giuliano Barbaro is the CEO of CenterVue, as recorded in our data. They have also founded this company.

CenterVue is a funded company, having raised a total of $911K across 1 funding round to date. The company's 1st funding round was a Seed of $911K, raised on Jun 2011.

CenterVue, a M31 alumnus, develops fundus imaging diagnostic devices for early detection of eye diseases such as Diabetic Retinopathy, Macular Degeneration and Glaucoma. Its products include the DRS whichis a traditional fundus camera, the Compass which is a Fundus Automated Perimeter that combines Visual Field measurement to TrueColor Confocal Imaging of the optic disc and RNFL, the Eidon is the a TrueColor Confocal Scanner that combines the advantages of SLO with the fidelity of true color fundus imaging, and the Maia device combines Images, Sensitivity and Fixation analysis for confocal microperimetry to assess macula integrity. Apart from these devices, Centervue also provides EKN which is an internet based software system, integrated with the DRS fundus camera and used to transmit retinal images and textual information, making them available for online consultation by authorized users, via the regular internet browser. CenterVue sells its products worldwide in more than 70 countries and a US subsidiary was started in 2010.

CenterVue has 2 investors. Key investors include Revenio Group, and Sofimac Investment Managers.

Yes. CenterVue was acquired by Revenio Group in April 2019.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available